Key result
Acute thromboembolic events in Takotsubo cardiomyopathy were associated with a significantly higher mortality rate over a mean 3-year follow-up compared to patients without such events (P=0.02).
Why the study?
Does the presence of acute thromboembolic events affect mortality in patients with Takotsubo cardiomyopathy?
Population
114 consecutive patients diagnosed with Takotsubo cardiomyopathy (TTC) between January 2003 and September 2015
Comparison
Presence of acute thromboembolic events on index… vs Patients with Takotsubo cardiomyopathy without…
Design
Cohort
Follow-up
mean 3 years
Authors
Loading...
Supports risk stratification by thromboembolic events in Takotsubo cardiomyopathy; leaves open whether anticoagulation improves survival.
Cohort (n=114)
Does the presence of acute thromboembolic events affect mortality in patients with Takotsubo cardiomyopathy?
p-value: p=0.02
Acute thromboembolic events occur in approximately 12% of patients with Takotsubo cardiomyopathy and are associated with significantly higher long-term mortality, suggesting a potential role for anticoagulation in high-risk patients.
El‐Battrawy et al. (2016) conducted a cohort in Takotsubo cardiomyopathy (n=114). Acute thromboembolic events vs. No acute thromboembolic events was evaluated on Mortality (p=0.02). Acute thromboembolic events in Takotsubo cardiomyopathy were associated with a significantly higher mortality rate over a mean 3-year follow-up compared to patients without such events (P=0.02).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: